tiprankstipranks
Trending News
More News >
Rani Therapeutics Holdings, Inc. Class A (RANI)
NASDAQ:RANI
US Market

Compare Rani Therapeutics Holdings (RANI) vs. Competitors

Compare
1,518 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Rani Therapeutics Holdings
$1.38
$162.84M
-1.62
-7.91%
3 Buy
0 Hold
0 Sell
Strong Buy
Tenax Therapeutics
$14.01
$87.47M
-11.79
119.18%
4 Buy
0 Hold
0 Sell
Strong Buy
Iterum Therapeutics
$0.34
$17.01M
-0.42
-79.13%
2 Buy
0 Hold
0 Sell
Moderate Buy
Annovis Bio
$3.04
$80.57M
-1.89
-42.54%
2 Buy
0 Hold
0 Sell
Moderate Buy
PolyPid
$4.72
$75.03M
-1.58
58.05%
3 Buy
0 Hold
0 Sell
Strong Buy
AN2 Therapeutics, Inc.
$1.14
$32.61M
-1.00
-4.24%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RANI
Rani Therapeutics Holdings
1.28
-0.10
-7.25%
TENX
Tenax Therapeutics
13.37
7.37
122.83%
ITRM
Iterum Therapeutics
0.31
-1.26
-80.06%
ANVS
Annovis Bio
2.81
-2.08
-42.54%
PYPD
PolyPid
4.71
1.72
57.53%
ANTX
AN2 Therapeutics, Inc.
1.13
-0.04
-3.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts